Non-muscarinic Therapeutic Targets for Acute Organophosphorus Poisoning

Journal of Medical Toxicology

Volumn 6, Issue 4, 2010, Pages 408-412

  Rosenbaum, Christopher ^a   Bird, Steven B ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Muscarinic; Nicotinic; Organophosphorus; Poisoning

Indexed keywords

ATROPINE; BENZODIAZEPINE; CHOLINESTERASE INHIBITOR; CLOFENVINFOS; DICROTOPHOS; DIMETHOATE; DISULFOTON; METHAMIDOPHOS; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; ORGANOPHOSPHATE INSECTICIDE; OXIME; PANCURONIUM; PARATHION;

ARTICLE; CHEMICAL WARFARE; CHOLINESTERASE INHIBITION; DEVELOPING COUNTRY; DRUG RESPONSE; DRUG TARGETING; HUMAN; INTOXICATION; LIPOPHILICITY; MORBIDITY; MORTALITY; NATIONAL HEALTH ORGANIZATION; NEUROMUSCULAR JUNCTION DISORDER; NONHUMAN; RESPIRATORY FAILURE;

ACUTE DISEASE; ANTIDOTES; INTUBATION, INTRATRACHEAL; NEUROMUSCULAR JUNCTION; NEUROTOXICITY SYNDROMES; ORGANOPHOSPHORUS COMPOUNDS; RESPIRATORY INSUFFICIENCY; RESPIRATORY MUSCLES;

EID: 78650040718     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-010-0093-7     Document Type: Article

References (48)

1. Eyer F, Meischner V, Kiderlen D et al (2003) Human parathion poisoning. A toxicokinetic analysis. Toxicol Rev 22: 143-163.
2. Zilker T, Hibler A (1996) Treatment of severe parathion poison: clinical aspects. In: Szinicz L, Eyer P, Klimmek R (eds) Role of oximes in the treatment of anticholinesterase agent poisoning. Spektrum, Akademischer, Heidelberg, pp 9-17.
3. Eddleston M, Eyer P, Worek F et al (2005) Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet 366: 1452-1459.
4. Sidell FR (1994) Clinical effects of organophosphorus cholinesterase inhibitors. J Appl Toxicol 14: 111-113.
5. Thiermann H, Szinicz L, Eyer P et al (2005) Correlation between red blood cell acetylcholinesterase activity and neuromuscular transmission in organophosphate poisoning. Chem Biol Interact 157-158: 345-347.
6. Eddleston M, Dawson A, Karalliedde L et al (2004) Early management after self-poisoning with an organophosphorus or carbamate pesticide-a treatment protocol for junior doctors. Crit Care 8: R391-397.
7. Sivilotti ML, Bird SB, Lo JC et al (2006) Multiple centrally acting antidotes protect against severe organophosphate toxicity. Acad Emerg Med 13: 359-364.
8. Bird SB, Gaspari RJ, Dickson EW (2003) Early death due to severe organophosphate poisoning is a centrally mediated process. Acad Emerg Med 10: 295-298.
9. Eddleston M, Singh S, Buckley N (2005) Organophosphorus poisoning (acute). Clin Evid 9: 1744-1755.
10. Ballantyne B, Marrs TC (1992) Overview of the biological and clinical aspects of organophosphates and carbamates. Clinical and experimental toxicology of organophosphate and carbamates. Butterworth Heinemann, Oxford, pp 3-14.
11. Eddleston M, Eyer P, Worek F et al (2009) Pralidoxime in acute organophosphorus insecticide poisoning-a randomised controlled trial. PLoS medicine 6: e1000104.
12. Senanayake N, Karalliedde L (1987) Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N Engl J Med 316: 761-763.
13. Senanayake N, Johnson MK (1982) Acute polyneuropathy after poisoning by a new organophosphate insecticide. The New England journal of medicine 306: 155-157.
14. Li Y, Yu X, Wang Z et al (2006) Gastric lavage in acute organophosphorus pesticide poisoning (GLAOP)-a randomised controlled trial of multiple vs. single gastric lavage in unselected acute organophosphorus pesticide poisoning. BMC emergency medicine 6: 10.
15. Avasthi G, Singh G (2000) Serial neuro-electrophysiological studies in acute organophosphate poisoning-correlation with clinical findings, serum cholinesterase levels and atropine dosages. J Assoc Physicians India 48: 794-799.
16. Jayawardane P, Senanayake N, Dawson A (2009) Electrophysiological correlates of intermediate syndrome following acute organophosphate poisoning. Clinical toxicology Philadelphia, Pa 47: 193-205.
17. Singh G, Sidhu UP, Mahajan R et al (2000) Phrenic nerve conduction studies in acute organophosphate poisoning. Muscle & nerve 23: 627-632.
18. Sedgwick EM, Senanayake N (1997) Pathophysiology of the intermediate syndrome of organophosphorus poisoning. Journal of neurology, neurosurgery, and psychiatry 62: 201-202.
19. Karalliedde L, Henry JA (1993) Effects of organophosphates on skeletal muscle. Human & experimental toxicology 12: 289-296.
20. De Bleecker J, van den Neucker K, Colardyn F (1993) Intermediate syndrome in organophosphorus poisoning: a prospective study. Critical care medicine 21: 1706-1711.
21. Benson B, Tolo D, McIntire M (1992) Is intermediate syndrome in organophosphate poisoning the result of insufficient oxime therapy. J Toxicol Clin Toxicol 30: 347-349.
22. John M, Oommen A, Zachariah A (2003) Muscle injury in organophosphorous poisoning and its role in the development of intermediate syndrome. Neurotoxicology 24: 43-53.
23. Dandapani M, Zachariah A, Kavitha MR et al (2003) Oxidative damage in intermediate syndrome of acute organophosphorous poisoning. The Indian journal of medical research 117: 253-259.
24. Katz EJ, Cortes VI, Eldefrawi ME et al (1997) Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: relevance to their toxicities. Toxicology and applied pharmacology 146: 227-236.
25. De Bleecker J, Vogelaers D, Ceuterick C et al (1992) Intermediate syndrome due to prolonged parathion poisoning. Acta neurologica Scandinavica 86: 421-424.
26. De Bleecker J, Lison D, van Den Abeele K et al (1994) Acute and subacute organophosphate poisoning in the rat. Neurotoxicology 15: 341-348.
27. De Bleecker JL (1995) The intermediate syndrome in organophosphate poisoning: an overview of experimental and clinical observations. J Toxicol Clin Toxicol 33: 683-686.
28. Jayawardane P, Dawson AH, Weerasinghe V et al (2008) The spectrum of intermediate syndrome following acute organophosphate poisoning: a prospective cohort study from Sri Lanka. PLoS medicine 5: e147.
29. Pond W, Houpt K (1978) The pig as a model in biomedical research. Comstock, London.
30. Larsen M, Rolin B (2004) Use of the Gottingen minipig as a model of diabetes, with special focus on type 1 diabetes research. ILAR Journal 45: 303-313.
31. Skytte C, Makin A (2008) Measurement of cardiovascular effects in minipigs using telemetry. J Pharmacol Toxicol 58: 172.
32. Thiermann H, Eyer P, Worek F et al (2005) Effects of oximes on muscle force and acetylcholinesterase activity in isolated mouse hemidiaphragms exposed to paraoxon. Toxicology 214: 190-197.
33. Eddleston M, Mohamed F, Davies JO et al (2006) Respiratory failure in acute organophosphorus pesticide self-poisoning. QJM 99: 513-522.
34. Schiavo G, Matteoli M, Montecucco C (2000) Neurotoxins affecting neuroexocytosis. Phys Rev 80: 717-766.
35. Sollner T, Whiteheart SW, Brunner M et al (1993) SNAP receptors implicated in vesicle targeting and fusion. Nature 362: 318-324.
36. Schwartz JH (1991) Principles of Neural Science 3 rd ed. Appleton and Lange, Norwalk.
37. Lotti M (2001) Clinical toxicology of anticholinesterase agents in humans. Handbook of Pesticide Toxicology. Academic, San Diego, pp 1043-1085.
38. Evron T, Geyer BC, Cherni I et al (2007) Plant-derived human acetylcholinesterase-R provides protection from lethal organophosphate poisoning and its chronic aftermath. Faseb J 21: 2961-2969.
39. Colombo A, Orsi F, Bonfanti P (2005) Exposure to the organophosphorus pesticide chlorpyrifos inhibits acetylcholinesterase activity and affects muscular integrity in Xenopus laevis larvae. Chemosphere 61: 1665-1671.
40. Wecker L, Mrak RE, Dettbarn WD (1986) Evidence of necrosis in human intercostal muscle following inhalation of an organophosphate insecticide. Fundam Appl Toxicol 6: 172-174.
41. Tuler SM, Bowen JM (1989) Toxic effects of organophosphates on nerve cell growth and ultrastructure in culture. J Toxicol Environ Health 27: 209-223.
42. Flynn CJ, Wecker L (1986) choline levels in brain. A non-cholinergic component of organophosphate toxicity. Biochemical pharmacology 35: 3115-3121.
43. Worek F, Mast U, Kiderlen D et al (1999) Improved determination of acetylcholinesterase activity in human whole blood. Clin Chim Acta 288: 73-90.
44. Padmaja D, Mantha S (2002) Monitoring of Neuromuscular Juntion. Ind J Anaesth 46: 279-288.
45. Sheridan RD, Smith AP, Turner SR et al (2005) Nicotinic antagonists in the treatment of nerve agent intoxication. J R Soc Med 98: 114-115.
46. White SM, Palfreman TM (2005) Nicotinic antagonists and nerve gas poisoning. J R Soc Med 98: 336.
47. Breningstall GN, Kurachek SC, Fugate JH et al (1996) Treatment of congenital endplate acetylcholinesterase deficiency by neuromuscular blockade. J Child Neurol 11: 345-346.
48. Besser R, Vogt T, Gutmann L (1990) Pancuronium improves the neuromuscular transmission defect of human organophosphate intoxication. Neurology 40: 1275-1277.